BioCentury
ARTICLE | Company News

EC approves ViiV's Tivicay

January 22, 2014 2:14 AM UTC

The European Commission approved Tivicay dolutegravir from ViiV Healthcare Ltd. to treat HIV infection in combination with other antiretroviral agents in patients ages 12 years and older. FDA approved...